Kirsten E. Smith
Impact in
- Pharmacology top 1%
- Alkaloids: synthesis and pharmacology
- Berberine and alkaloids research
- Biochemistry top 2%
- Traditional and Medicinal Uses of Annonaceae
Papers in
- Pharmacology 25
- Alkaloids: synthesis and pharmacology 24
- Berberine and alkaloids research 6
- Biochemistry 19
- Traditional and Medicinal Uses of Annonaceae 19
- Co-authors
- Oliver Grundmann (16 shared papers)Jeffrey M. Rogers (9 shared papers)David H. Epstein (17 shared papers)Albert Garcia‐Romeu (6 shared papers)Marc T. Swogger (5 shared papers)Kelly E. Dunn (7 shared papers)Justin C. Strickland (4 shared papers)Christopher R. McCurdy (10 shared papers)
- Journals
- Journal of Addiction Medicine (5 papers)Drug and Alcohol Dependence (4 papers)Current Addiction Reports (3 papers)Experimental and Clinical Psychopharmacology (3 papers)Frontiers in Pharmacology (2 papers)
- Partner nations
- United StatesMalaysiaUnited Kingdom
In The Last Decade
Kirsten E. Smith
35 papers receiving 405 citations
Peers
Comparison fields: 5 of 56
- Pharmacology 296
- Biochemistry 238
- Organic Chemistry 181
- Biological Psychiatry 11
- Pharmacology 67
Countries citing papers authored by Kirsten E. Smith
This map shows the geographic impact of Kirsten E. Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kirsten E. Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kirsten E. Smith more than expected).
Fields of papers citing papers by Kirsten E. Smith
This network shows the impact of papers produced by Kirsten E. Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kirsten E. Smith. The network helps show where Kirsten E. Smith may publish in the future.
Co-authors
The 25 scholars most cited alongside Kirsten E. Smith, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 38 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 51 | |
| 2 | 2022 | 42 | |
| 3 | 2021 | 35 | |
| 4 | 2021 | 23 | |
| 5 | 2021 | 20 | |
| 6 | 2024 | 19 | |
| 7 | 2022 | 16 | |
| 8 | 2024 | 16 | |
| 9 | 2022 | 15 | |
| 10 | 2024 | 15 | |
| 11 | 2023 | 13 | |
| 12 | 2023 | 12 | |
| 13 | 2022 | 11 | |
| 14 | 2023 | 11 | |
| 15 | 2025 | 10 | |
| 16 | 2023 | 10 | |
| 17 | 2023 | 10 | |
| 18 | 2024 | 9 | |
| 19 | 2022 | 9 | |
| 20 | 2023 | 8 |
About Kirsten E. Smith
Kirsten E. Smith is a scholar working on Pharmacology, Biochemistry, Organic Chemistry, Pharmacology and Clinical Psychology, having authored 38 papers that have together received 410 indexed citations. Recurring topics across this work include Alkaloids: synthesis and pharmacology (24 papers), Traditional and Medicinal Uses of Annonaceae (19 papers), Chemical synthesis and alkaloids (14 papers), Berberine and alkaloids research (6 papers), Opioid Use Disorder Treatment (3 papers), Substance Abuse Treatment and Outcomes (3 papers), Schizophrenia research and treatment (3 papers) and Mental Health Research Topics (3 papers). The work is most often cited by research in Pharmacology (296 citations), Biochemistry (238 citations), Organic Chemistry (181 citations), Biological Psychiatry (11 citations) and Pharmacology (67 citations). Kirsten E. Smith has collaborated with scholars based in United States, Malaysia and United Kingdom. Frequent co-authors include Oliver Grundmann, Jeffrey M. Rogers, David H. Epstein, Albert Garcia‐Romeu, Marc T. Swogger, Kelly E. Dunn, Justin C. Strickland, Christopher R. McCurdy, Jack E. Henningfield and Leigh V. Panlilio. Their work appears in journals such as Journal of Addiction Medicine, Drug and Alcohol Dependence, Current Addiction Reports, Experimental and Clinical Psychopharmacology and Frontiers in Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.